Overactive Bladder (OAB) Drink Advice Study
NCT00982241 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2012-07-24
Summary
The researchers want to investigate how fluid intake influences the symptoms of OAB. The researchers will recruit 45 patients with OAB and randomize them (blind) in 3 groups (low/normal/high fluid intake). Patients will follow this drink pattern for 2-5 days, while filling in an standard micturation diary for 2 days. This micturation diary is coupled to: collection of multiple urine samples, urine pH measurements, and a Perception of Intensity of Urgency Scale (PPIUS) scoring table. All this is collected by the patients themselves. Urine samples will be analysed for osmolality by the clinical chemistry department.
Conditions
- Overactive Bladder Syndrome
Interventions
- DIETARY_SUPPLEMENT
-
water
drinking water / normal dietary fluids for oral intake
Sponsors & Collaborators
-
Radboud University Medical Center
lead OTHER
Principal Investigators
-
John Heesakkers, dr. MD · dept of Urology, Radboud University Nijmegen Medical Centre
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2010-12-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Caffeine Reduction and Overactive Bladder Symptoms
NCT00754260 ·Status: TERMINATED ·Phase: NA
-
A Study Measuring and Tracking Changes in Overactive Bladder (OAB) Medication
NCT01317810 ·Status: WITHDRAWN
-
Overactive Bladder Education
NCT02505607 ·Status: TERMINATED ·Phase: NA
-
"Swallow my Urine Back" : Inhibition of Detrusor Overactivity by Swallowing Maneuver
NCT01408771 ·Status: COMPLETED
-
A Pilot Trial in a Sleep Laboratory Setting to Observe Night Time Bladder Function of Subjects With Overactive Bladder (OAB)
NCT01099345 ·Status: TERMINATED
-
Age-specific Prevalence and Comparisons of UDS and Bladder Diary Between OAB-wet and -Dry Women
NCT03807024 ·Status: COMPLETED
-
OnabotulinumtoxinA Bladder Injection Study
NCT03523091 ·Status: TERMINATED ·Phase: PHASE4
-
Prevalence And Risk Factors of Overactive Bladder Syndrome Among Egyptian Medical Students, and Their Impact On Health-Related Quality Of Life
NCT07044778 ·Status: COMPLETED
-
Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity
NCT00335660 ·Status: TERMINATED ·Phase: PHASE2
-
Study of AOBO-001 for Overactive Bladder With Urge Urinary Incontinence and Frequency
NCT01294982 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of AGN-214868 in Patients With Idiopathic Overactive Bladder and Urinary Incontinence
NCT01157377 ·Status: COMPLETED ·Phase: PHASE2
-
Local Anesthetic Treatments for Overactive Bladder
NCT00427648 ·Status: TERMINATED ·Phase: PHASE3
-
A Study on Anticholinergic Use: Attribution of Overactive Bladder (OAB) Medications to the Anticholinergic Burden
NCT03903094 ·Status: COMPLETED
-
Evaluating a Digital Intervention for Overactive Bladder
NCT05170100 ·Status: COMPLETED ·Phase: NA
-
Validation of a Real-time Urodynamic Measure of Urinary Urgency
NCT00909428 ·Status: COMPLETED ·Phase: PHASE4
-
Assessing the OAB-8 Questionnaire as a Tool to Measure Treatment Outcome
NCT00313924 ·Status: UNKNOWN ·Phase: PHASE4
-
Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder
NCT01868516 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
NCT02386072 ·Status: COMPLETED
-
Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection
NCT05719285 ·Status: COMPLETED ·Phase: PHASE4
-
ELB245 for 12 Weeks Versus 4mg Tolterodine in Patients With Incontinent Overactive Bladder (OAB)
NCT00439192 ·Status: TERMINATED ·Phase: PHASE2
-
AQUA: Anticholinergic Side Effects QUestionnAire
NCT04791111 ·Status: COMPLETED
-
A Two-week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Years) With Neurogenic Detrusor Overactivity
NCT00712322 ·Status: TERMINATED ·Phase: PHASE2
-
Developing a Simple Test to Diagnose Overactive Bladder
NCT05572918 ·Status: UNKNOWN
-
Efficacy, Tolerability and Impact on Quality of Life of Propiverine in Patients With Overactive Bladder Syndrome
NCT02024945 ·Status: COMPLETED
-
Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A
NCT04305743 ·Status: RECRUITING ·Phase: PHASE4